Top Tag

The U.S. Intelligence Community

The Food and Drug Administration on Friday reversed its emergency use authorization for Sotrovimab, the monoclonal antibody used to treat COVID-19, in eight states, Puerto Rico, and the U.S. Virgin Islands, because it is not effective against the new BA.2 variant.

You may also like

Home Ethos About Contact
Terms Policy GDPR RichTVX
© Saeculum XXI U.S. Intelligence News